October 2024
Cochlear-backed medtech Epiminder seeks $200m val in pre-IPO raise
The company expects its implants to be commercially available in the US market in 2027.
- Sarah Thompson, Kanika Sood and Emma Rapaport
June 2024
How this Australian banker thrived on Wall Street for 30 years
Queenslander Paul Compton, who started a job at Jamie Dimon’s JP Morgan in 2007, knows that the industry can be a rough ride.
- Matthew Cranston
October 2020
Cochlear-backed medical devices outfit closes $18m Series A round
ASX-listed hearing device behemoth Cohclear has reached into its pocket again to finance the growth of a Melbourne-based medical devices start-up.
- Sarah Thompson, Anthony Macdonald and Tim Boyd